Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19591 | 434 | 31.6 | 60% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1647 | 6393 | WALL SHEAR STRESS//SHEAR STRESS//CAROTID BIFURCATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | VESSEL SIMULATING FLOW THROUGH CELL | Author keyword | 11 | 100% | 1% | 6 |
| 2 | LOCAL PHARMACOKINETICS | Author keyword | 4 | 75% | 1% | 3 |
| 3 | PATHOPHARMACOL UNIT | Address | 4 | 75% | 1% | 3 |
| 4 | LOW DENSITY LIPOPROTEIN TRANSPORT | Author keyword | 4 | 46% | 1% | 6 |
| 5 | ARTERIAL WALL TRANSPORT | Author keyword | 3 | 57% | 1% | 4 |
| 6 | MULTI LAYERED POROUS MEDIA | Author keyword | 3 | 100% | 1% | 3 |
| 7 | MULTILAYERED ARTERIAL WALL | Author keyword | 3 | 100% | 1% | 3 |
| 8 | ENERGY PHENOMENA | Address | 3 | 60% | 1% | 3 |
| 9 | CARDIAC THER IES | Address | 2 | 67% | 0% | 2 |
| 10 | FENESTRAL PORE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LOCAL PHARMACOKINETICS | 21 | 78% | 3% | 14 |
| 2 | LDL TRANSPORT | 12 | 63% | 3% | 12 |
| 3 | HEPARIN DEPOSITION | 12 | 86% | 1% | 6 |
| 4 | RABBIT THORACIC AORTA | 11 | 33% | 6% | 28 |
| 5 | I 125 LABELED ALBUMIN | 11 | 100% | 1% | 6 |
| 6 | I 131 ALBUMIN | 8 | 70% | 2% | 7 |
| 7 | ALBUMIN TRANSPORT | 8 | 56% | 2% | 10 |
| 8 | THORACIC AORTA INVIVO | 6 | 71% | 1% | 5 |
| 9 | MACROMOLECULAR TRANSPORT | 6 | 27% | 4% | 18 |
| 10 | ELASTIC LAMINA AFFECTS | 3 | 57% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis | 1996 | 102 | 82 | 45% |
| Drug-eluting stents: Factors governing local pharmacokinetics | 2006 | 38 | 22 | 82% |
| Factors that affect mass transport from drug eluting stents into the artery wall | 2010 | 8 | 53 | 32% |
| Evolution of implantable and insertable drug delivery systems | 2014 | 4 | 33 | 12% |
| Release profiles in drug-eluting stents: Issues and uncertainties | 2007 | 83 | 47 | 11% |
| MECHANISM OF CONTROLLED RELEASE KINETICS FROM MEDICAL DEVICES | 2010 | 5 | 44 | 32% |
| Mechanisms of controlled drug release from drug-eluting stents | 2006 | 146 | 30 | 10% |
| The future of drug eluting stents | 2006 | 11 | 19 | 21% |
| Improving the drug selection and development process for combination devices | 2007 | 4 | 45 | 7% |
| THE EFFECT OF 5-HYDROXYTRYPTAMINE AND ARTERIAL BLOOD WITHDRAWAL ON CEREBRAL MICRO-CIRCULATION IN THE CAT, ARTERIAL PERMEABILITY IN THE RABBIT | 1983 | 3 | 6 | 33% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PATHOPHARMACOL UNIT | 4 | 75% | 0.7% | 3 |
| 2 | ENERGY PHENOMENA | 3 | 60% | 0.7% | 3 |
| 3 | CARDIAC THER IES | 2 | 67% | 0.5% | 2 |
| 4 | MATH MODELLING SCI COMP MOX | 2 | 67% | 0.5% | 2 |
| 5 | AMES BIOENGN MED | 1 | 100% | 0.5% | 2 |
| 6 | NEW BUSINESS VENTURE | 1 | 100% | 0.5% | 2 |
| 7 | PHARM BIOPHARMACEUT PHARMACEUT TECHNOL | 1 | 27% | 0.9% | 4 |
| 8 | BIO ABORAT BIO5 | 1 | 33% | 0.7% | 3 |
| 9 | MAT SCI ENGN S | 1 | 33% | 0.5% | 2 |
| 10 | CABER | 1 | 15% | 1.2% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000194166 | WALL SHEAR STRESS//CAROTID BIFURCATION//OSCILLATORY SHEAR INDEX |
| 2 | 0.0000190684 | AGE RELATED DECREASE IN PGI2 PRODUCTION//EN FACE TECHNIQUE//15 ISOPROSTANE F 2T |
| 3 | 0.0000189141 | ENDOTHELIAL GLYCOCALYX//GLYCOCALYX//ENDOTHELIAL SURFACE LAYER |
| 4 | 0.0000136532 | SMOOTH MUSCLE CELLS PROLIFERATION//WALLENBERG VASC//ARTIFICIAL ORGAN SUR E ENGN SICHUAN |
| 5 | 0.0000128995 | DIABET CELL BIOL//CELL BIOL DIABET//LOW DENSITY LIPOPROTEIN RETENTION |
| 6 | 0.0000118892 | DRUG ELUTING STENT//DRUG ELUTING STENTS//STENT THROMBOSIS |
| 7 | 0.0000110686 | STENT ARTERY INTERACTION//HYBRID CATHETERIZAT ELE OPHYSIOL//STENT FATIGUE LIFE |
| 8 | 0.0000102262 | ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL |
| 9 | 0.0000086139 | EXTRACELLULAR MATRIX STRUCTURES//FORMIC ACID DIGESTION//CHICKEN AV PURKINJE RING |
| 10 | 0.0000076163 | NANONEUROSURGERY//DIMER PLACEMENT//POSITIONAL CONTROL |